These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 36515740)
1. Treatment modalities of ALK-positive relapsed/refractory inflammatory myofibroblastic tumor of the brain and lungs in 7-year-old girl: case-based reviews. Chanthong S; Sathitsamitphong L; Natesirinilkul R; Charoenkwan P; Suwansirikul S; Choed-Amphai C Childs Nerv Syst; 2023 Feb; 39(2):331-342. PubMed ID: 36515740 [TBL] [Abstract][Full Text] [Related]
2. A Comparative Study of Inflammatory Myofibroblastic Tumors and Tumefactive IgG4-related Inflammatory Lesions: the Relevance of IgG4 Plasma Cells. Chougule A; Bal A; Das A; Agarwal R; Singh N; Rao KL Appl Immunohistochem Mol Morphol; 2016; 24(10):721-728. PubMed ID: 26469330 [TBL] [Abstract][Full Text] [Related]
3. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS. Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: a diagnostic dilemma. Bhagat P; Bal A; Das A; Singh N; Singh H Virchows Arch; 2013 Dec; 463(6):743-7. PubMed ID: 24100523 [TBL] [Abstract][Full Text] [Related]
5. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-year-old child. Höhne S; Milzsch M; Adams J; Kunze C; Finke R Tumori; 2015; 101(3):249-56. PubMed ID: 25983099 [TBL] [Abstract][Full Text] [Related]
7. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS Front Oncol; 2022; 12():761558. PubMed ID: 35237506 [TBL] [Abstract][Full Text] [Related]
8. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report. Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the lung involving the central nervous system in pediatric patients. Ramos JG; Ochoa A; Cicutti S; Del Rio R; Lubienieki F Childs Nerv Syst; 2023 May; 39(5):1137-1145. PubMed ID: 37017800 [TBL] [Abstract][Full Text] [Related]
10. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Yamamoto H; Yamaguchi H; Aishima S; Oda Y; Kohashi K; Oshiro Y; Tsuneyoshi M Am J Surg Pathol; 2009 Sep; 33(9):1330-40. PubMed ID: 19718789 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation. Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory myofibroblastic tumors of the central nervous system that express anaplastic lymphoma kinase have a high recurrence rate. Denis DJ; Elayoubi K; Weil AG; Berthelet F; Bojanowski MW Surg Neurol Int; 2013; 4():70. PubMed ID: 23776756 [TBL] [Abstract][Full Text] [Related]
15. Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study. Gadgeel SM; Gandhi L; Riely GJ; Chiappori AA; West HL; Azada MC; Morcos PN; Lee RM; Garcia L; Yu L; Boisserie F; Di Laurenzio L; Golding S; Sato J; Yokoyama S; Tanaka T; Ou SH Lancet Oncol; 2014 Sep; 15(10):1119-28. PubMed ID: 25153538 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Swain RS; Tihan T; Horvai AE; Di Vizio D; Loda M; Burger PC; Scheithauer BW; Kim GE Hum Pathol; 2008 Mar; 39(3):410-9. PubMed ID: 18261625 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
19. Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation. Ou SH; Weitz M; Jalas JR; Kelly DF; Wong V; Azada MC; Quines O; Klempner SJ Lung Cancer; 2016 Jun; 96():15-8. PubMed ID: 27133743 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor]. Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]